CTX — Captor Therapeutics SA Balance Sheet
0.000.00%
Last trade - 00:00- PLN233.31m
- PLN186.02m
- PLN15.83m
Annual balance sheet for Captor Therapeutics SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 10.7 | 118 | 90.9 | 75.7 | 39.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.75 | 11.7 | 9.68 | 12.6 | 38.3 |
| Prepaid Expenses | |||||
| Total Current Assets | 13.2 | 131 | 101 | 88.6 | 78.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12.2 | 12.6 | 10.7 | 6.95 | 7.86 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 25.8 | 144 | 113 | 97.3 | 87.5 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20 | 16.4 | 13.4 | 26.7 | 20 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 26.8 | 19.3 | 16.7 | 28.1 | 23 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | -1 | 124 | 96.3 | 69.2 | 64.5 |
| Total Liabilities & Shareholders' Equity | 25.8 | 144 | 113 | 97.3 | 87.5 |
| Total Common Shares Outstanding |